Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Management of Cancer Pain With Oral Controlled‐Release Morphine Sulfate
Steven D. Meed
, Phyllis M. Kleinman
, Thomas G. Kantor
, Ronald H. Blum
, John J. Savarese
Research output
:
Contribution to journal
›
Article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of Cancer Pain With Oral Controlled‐Release Morphine Sulfate'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Morphine Sulfate
100%
Cancer Pain
100%
Dose Rate
18%
Analgesia
18%
Morphine
18%
Immediate Release
18%
Quality of Life
9%
Constipation
9%
Cancer Patients
9%
Opioid Analgesics
9%
Increased Dose
9%
Delivery System
9%
Nausea
9%
Blood Levels
9%
Pain Relief
9%
Analgesic Drugs
9%
Chronic Morphine
9%
Sedation
9%
American Colleges
9%
Drug Tolerance
9%
Clinical Pharmacology
9%
μ-opioid Receptor
9%
Dosing Schedule
9%
Respiratory Difficulty
9%
Parenteral Medication
9%
Equianalgesic
9%
Pharmacology, Toxicology and Pharmaceutical Science
MS Contin
100%
Cancer Pain
100%
Side Effect
18%
Morphine
18%
Malignant Neoplasm
9%
Analgesic Agent
9%
Constipation
9%
Nausea
9%
Narcotic Analgesic Agent
9%
Drug Tolerability
9%
Clinical Pharmacology
9%
Equianalgesic
9%